Amexdrug Stock Performance
| AXRX Stock | USD 0 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Amexdrug are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Amexdrug has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Amexdrug is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Amexdrug |
Amexdrug Relative Risk vs. Return Landscape
If you would invest 0.20 in Amexdrug on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Amexdrug or generate 0.0% return on investment over 90 days. Amexdrug is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Amexdrug, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amexdrug Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amexdrug's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Amexdrug, and traders can use it to determine the average amount a Amexdrug's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AXRX |
Based on monthly moving average Amexdrug is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amexdrug by adding Amexdrug to a well-diversified portfolio.
Amexdrug Fundamentals Growth
Amexdrug Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Amexdrug, and Amexdrug fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amexdrug Pink Sheet performance.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 34.51 M | |||
| Shares Outstanding | 169.11 M | |||
| Price To Earning | 165.00 X | |||
| Price To Book | 51.38 X | |||
| Price To Sales | 3.04 X | |||
| Revenue | 10.43 M | |||
| EBITDA | 380.83 K | |||
| Cash And Equivalents | 168.01 K | |||
| Total Debt | 961.12 K | |||
| Debt To Equity | 1.46 % | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | 27.49 K | |||
| Total Asset | 2.31 M | |||
| Retained Earnings | 961 K | |||
| Current Asset | 1.76 M | |||
| Current Liabilities | 798 K | |||
About Amexdrug Performance
Evaluating Amexdrug's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Amexdrug has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amexdrug has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California. AMEXDRUG CORPORATION operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 9 people.Things to note about Amexdrug performance evaluation
Checking the ongoing alerts about Amexdrug for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Amexdrug help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amexdrug generated a negative expected return over the last 90 days | |
| Amexdrug has some characteristics of a very speculative penny stock |
- Analyzing Amexdrug's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amexdrug's stock is overvalued or undervalued compared to its peers.
- Examining Amexdrug's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amexdrug's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amexdrug's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amexdrug's pink sheet. These opinions can provide insight into Amexdrug's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Amexdrug Pink Sheet Analysis
When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.